Insulin—whether endogenous or exogenous—appears to be a significant contributor to increased fracture risk, and since few of our subjects were treated with insulin, our population may not have had sufficient T2D osteopathy to have detectable between‐group differences. This evidence concerns the gene INS and type 2 diabetes mellitus.